CBOA
SCLN

Commonwealth Bank of Australia’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Commonwealth Bank of Australia’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-50,671
Closed -$231K – 1149
2014
Q1 		$231K Sell
50,671
-7,263
-13% -$35.1K ﹤0.01% 1185
2013
Q4 		$292K Hold
57,934
– – ﹤0.01% 1131
2013
Q3 		$294K Buy
57,934
+53,993
+1,370% +$301K ﹤0.01% 1099
2013
Q2 		$20K Buy
+3,941
New +$18.8K ﹤0.01% 1247

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QBFM
QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return

Commonwealth Bank of Australia's SCLN Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2014, closing a stake of 50,671 shares — an estimated $231K sold.

Commonwealth Bank of Australia first reported a position in SCLN in Q2 2013 and held it in 4 quarters. The position peaked at $294K in Q3 2013. 95 funds tracked by Wall St. Rank hold SCLN as of Q2 2014.

  • Commonwealth Bank of Australia reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 50,671 Sciclone Pharmaceuticals Inc shares in Q2 2014, an estimated $231K.
  • Commonwealth Bank of Australia first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Commonwealth Bank of Australia's Sciclone Pharmaceuticals Inc position peaked at $294K in Q3 2013.
  • 95 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.